HomeInsightsResults

Morepen Laboratories Ltd Quarterly Result

Morepen Laboratories Ltd Quarterly Result

stocks purchased

₹ 2.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

368.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

Net Profit

₹ 34.85

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Morepen Laboratories Ltd for the Sep '24 is ₹ 442.71 crore as compare to the Jun '24 revenue of ₹ 458.64 crore. This represent the decline of -3.4733174%.
  • The ebitda of Morepen Laboratories Ltd for the Sep '24 is ₹ 49.06 crore as compare to the Jun '24 ebitda of ₹ 55.05 crore. This represent the decline of -10.881013%.
  • The net profit of Morepen Laboratories Ltd for the Sep '24 is ₹ 34.85 crore as compare to the Jun '24 net profit of ₹ 36.17 crore. This represent the decline of -3.6494327%.

Results Analysis

Market Price of Morepen Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Morepen Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202474.05
21 Nov 202473.21
19 Nov 202475.87
18 Nov 202474.22
14 Nov 202475.62
13 Nov 202475.52
12 Nov 202479.94
11 Nov 202480.26
08 Nov 202483.31
07 Nov 202484.56

Historical Revenue of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Morepen Laboratories Ltd

No data available

* All values are in crore

Morepen Laboratories Ltd News Hub

News

Morepen Laboratories to discuss results

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 11 No...

Read more

08 Nov 202410:49

News

Morepen Laboratories schedules AGM

Morepen Laboratories announced that the Annual General Meeting (AGM) of the company will b...

Read more

12 Sep 202416:01

News

Morepen Laboratories appoints director

Morepen Laboratories has appointed Sharad Jain (DIN: 06423452) as an Independent Director,...

Read more

27 Aug 202415:31

News

Morepen Labs soars after stellar Q1 performance

Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period und...

Read more

12 Aug 202412:44

News

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Au...

Read more

10 Aug 202416:53

News

Morepen Laboratories successfully concludes QIP issue of Rs 200 cr

Morepen Laboratories announced the successful subscription of a Qualified Institutional Pl...

Read more

06 Aug 202409:09

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Morepen Laboratories Ltd Quarterly Result

What is the EPS of Morepen Laboratories Ltd stock?

The Earnings Per Share (EPS) of Morepen Laboratories Ltd is 2.4. An EPS is the amount of net income attributed to each share of a common stock.

How is Morepen Laboratories Ltd EPS calculated?

The EPS of Morepen Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Morepen Laboratories Ltd report its EPS?

Morepen Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Morepen Laboratories Ltd EPS?

Factors that influence the EPS of Morepen Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Morepen Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Morepen Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*